A Cross-sectional, Observational Study to Assess Quality of Life and Satisfaction of Young Women (Aged 18-29) Following 6 (±1) Months Using Jaydess® as Their Contraceptive Method - The JULIA Study.
Phase of Trial: Phase IV
Latest Information Update: 04 Jul 2017
At a glance
- Drugs Levonorgestrel (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Acronyms JULIA
- Sponsors Bayer
- 19 Oct 2016 Status changed from active, no longer recruiting to completed.
- 19 Jul 2016 Planned End Date changed from 1 Jun 2016 to 1 Aug 2016.
- 19 Jul 2016 Status changed from recruiting to active, no longer recruiting.